We use cookies. Do you accept them?
See more details in our Privacy Policy

Accept Reject
searchclose

PlatformOS

DeckSend

Agents

NEW
mail_outline Share by email
content_copy Copy to clipboard

Dima Elissa, MBA

CEO, Founder , VisMed•3D

Roles: Founder Subject Matter Expert Investor Founder Coach Candidate Approved Vendor

Expertise: Investment Fundraising People / HR Product Sales / Bizdev Marketing Operations

Member since Apr 2022 - 5 followers

Dima Elissa, MBA
Award-Winning Healthcare Tech-Entrepreneur,
Community Educator, Mentor, Leader, Maven

Dima Elissa is CEO of VisMed-3D Healthcare TechnologyTM a global strategic healthcare tech consultancy.

A recognized, in-demand speaker she is versed in advanced technologies including 3D-printing, blockchain, cybersecurity, data interoperability, media/marketing, and supply chain management delivering her insights across varied global enterprise markets.

She is a founding board member of both the DePaul University’s Driehaus College of Business, Women in Entrepreneurship Institute, the nation’s first comprehensive Institute integrating academic learning, research, incubation funding and public policy, and the globally recognized mHUB Chicago, a hardtech innovation hub.

Launching over 16 start-ups she brings real-world innovation experience to over 100 start-up mentees to grow and scale their new ventures.

Dima distinctively serves as the technology and innovation lead for AMWA’s (American Medical Women’s Association) JEDI (Justice, Equity, Diversity & Inclusion) initiative, board member at several academic, innovation hubs and life science organizations. As a healthcare leader and executive, she is entrusted to teach future physicians “Innovation in Medicine for Medical Professionals” at RUSH Medical College.

Dima holds a B.A. in Chemistry from Hanover College and has earned her MBA from Texas A&M’s May’s School of Business with a concentration in Finance. She is also a member of the Board of Trustees at Hanover College.

follow_the_signs Themes followed
follow_the_signs Companies followed
follow_the_signs People followed
comment Recent Comments